The KEGG enrichment analysis revealed that the AL compounds targeted multiple signaling pathways related to depression, which primarily include neuroactive ligand–receptor interaction, the calcium signaling pathway, dopaminergic synapse, the IL-17 signaling pathway, and the pathways of neurodegeneration. This evidence concerns the gene IL17A and depressive symptom measurement.